Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $379.70M
Last updated: Nov 17, 2026 at 4:10 PM ET
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Stock Chart
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a latest price of $9.55 on Nov 17, 2026, 46.3% below its 52-week high of $17.79. Its price fell 10.4% over the past 12 months.
Price Chart
From Apr 2024 to Oct 2026, its highest month-end close was $20.06 in Jul 2024 and its lowest $3.66 in May 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CTNM with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CTNM.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 40.4%, and over 6 months it fell 25.2%.
| Period | Change |
|---|---|
| 1 month | +28.4% |
| 3 months | -40.4% |
| 6 months | -25.2% |
| 12 months | -10.4% |
| 12 months, with dividends | -10.4% |
Price by Year
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $9.39 | -17.8% |
| 2025 | $11.43 | -22.0% |
Trading Range
The price is 13.3% below its 50-day average of $11.01 and 28.5% below its 200-day average of $13.35.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $9.55 | |
| 52-week high | $17.79 | -46.3% |
| 52-week low | $6.72 | +42.1% |
| 50-day average | $11.01 | -13.3% |
| 200-day average | $13.35 | -28.5% |
Price Risk
Over 3 years, its largest fall from a peak was 84.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.64 |
| Largest fall, 1 year | -59.7% |
| Largest fall, 3 years | -84.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CTNM
What is CTNM's 1-year price change?
Contineum Therapeutics, Inc. Class A Common Stock's price fell 10.4% over the past 12 months. With dividends included, the 12-month total return was -10.4%.
What is CTNM's 52-week high and low?
Contineum Therapeutics, Inc. Class A Common Stock's 52-week high is $17.79 and its 52-week low is $6.72. Its latest price of $9.55 on Nov 17, 2026 is 46.3% below the high.
What is CTNM's beta?
Contineum Therapeutics, Inc. Class A Common Stock's 1-year beta against the S&P 500 is 1.64, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.7%.
Is the CTNM chart free?
Yes. Advanced Charting for CTNM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CTNM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors